Nazartinib, 250mg

(R)-3-((tert-Butoxycarbonyl)amino)-3-(2-nitrophenyl)propanoic acid, 95.0%, 100mg

2-Fluoro-4-(trifluoromethyl)benzonitrile, 97.0%, 25g

Ethyl 2,4-dichloro-5-fluorobenzoate, 98%, 5g

2-methyl-1-(4-methylbenzoyl)piperazine, 95.0%, 5g

4-Methyl-2-(2-methylphenyl)pentanoic acid, 95%, 250mg

3,5-Diiodo-L-thyronine, 95.0%, 25g

3-Bromo-2-methoxypyridin-4-amine, 95.0%, 5g

Methyl 4-aminopyrimidine-5-carboxylate, 95.0%, 1g

Fmoc-D-His(Trt)-OH, 95%, 5g

cis,trans-5,9-Cyclododecadiene-cis-1,2-diol>98.0%(GC)25g

1-Phenylcyclohexanol>98.0%(GC)5g

2-Bromo-3-fluoroiodobenzene, 95.0%, 25g